Dr Diogo Camacho from the Wyss Institute at Harvard discusses new research into using machine learning algorithms to analyse RNA sequences and reveal potential drug targets.
List view / Grid view
Harvard's Wyss Institute
Filter the results
A CRISPR-Cas9 high-throughput strategy creates the possibility to rapidly profile and identify genes and DNA sequence variations key to different traits and diseases.
Amplifying patient-specific T cells outside the body could increase the efficiency of cancer immunotherapies...